| Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression LC Davies, N Heldring, N Kadri, K Le Blanc Stem cells 35 (3), 766-776, 2017 | 356 | 2017 |
| The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human É Korpos, N Kadri, R Kappelhoff, J Wegner, CM Overall, E Weber, ... Diabetes 62 (2), 531-542, 2013 | 163 | 2013 |
| Immunomodulatory type II natural killer T lymphocytes in health and disease S Rhost, S Sedimbi, N Kadri, SL Cardell Scandinavian journal of immunology 76 (3), 246-255, 2012 | 92 | 2012 |
| Live cell imaging in a micro-array of acoustic traps facilitates quantification of natural killer cell heterogeneity AE Christakou, M Ohlin, B Vanherberghen, MA Khorshidi, N Kadri, T Frisk, ... Integrative Biology 5 (4), 712-719, 2013 | 81 | 2013 |
| Expression of CD226 is associated to but not required for NK cell education AK Wagner, N Kadri, J Snäll, P Brodin, S Gilfillan, M Colonna, ... Nature communications 8 (1), 15627, 2017 | 72 | 2017 |
| Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: a phase II study E Boberg, L Bahr, G Afram, C Lindström, P Ljungman, N Heldring, ... Stem cells translational medicine 9 (10), 1190-1202, 2020 | 61 | 2020 |
| CD4+ type II NKT cells mediate ICOS and programmed death-1–dependent regulation of type 1 diabetes N Kadri, E Korpos, S Gupta, C Briet, L Löfbom, H Yagita, A Lehuen, ... The Journal of Immunology 188 (7), 3138-3149, 2012 | 59 | 2012 |
| The complement system is essential for the phagocytosis of mesenchymal stromal cells by monocytes C Gavin, S Meinke, N Heldring, KA Heck, A Achour, E Iacobaeus, ... Frontiers in immunology 10, 2249, 2019 | 45 | 2019 |
| Phenotypic and functional alterations of myeloid‐derived suppressor cells during the disease course of multiple sclerosis E Iacobaeus, I Douagi, R Jitschin, M Marcusson‐Ståhl, AT Andrén, ... Immunology and Cell Biology 96 (8), 820-830, 2018 | 45 | 2018 |
| Platelets made HLA deficient by acid treatment aggregate normally and escape destruction by complement and phagocytes in the presence of HLA antibodies S Meinke, P Sandgren, A Mörtberg, C Karlström, N Kadri, A Wikman, ... Transfusion 56 (2), 370-382, 2016 | 44 | 2016 |
| Dynamic regulation of NK cell responsiveness N Kadri, AK Wagner, S Ganesan, K Kärre, S Wickström, MH Johansson, ... Natural Killer Cells, 95-114, 2016 | 43 | 2016 |
| Circadian regulation of cochlear sensitivity to noise by circulating glucocorticoids CR Cederroth, J Park, V Basinou, BD Weger, E Tserga, H Sarlus, ... Current biology 29 (15), 2477-2487. e6, 2019 | 38 | 2019 |
| Selection, tuning, and adaptation in mouse NK cell education N Kadri, T Luu Thanh, P Höglund Immunological reviews 267 (1), 167-177, 2015 | 38 | 2015 |
| Current perspectives on mesenchymal stromal cell therapy for graft versus host disease N Kadri, S Amu, E Iacobaeus, E Boberg, K Le Blanc Cellular & Molecular Immunology 20 (6), 613-625, 2023 | 32 | 2023 |
| Short and long term clinical and immunologic follow up after bone marrow mesenchymal stromal cell therapy in progressive multiple sclerosis—a phase I study E Iacobaeus, N Kadri, K Lefsihane, E Boberg, C Gavin, ... Journal of Clinical Medicine 8 (12), 2102, 2019 | 28 | 2019 |
| Independent control of natural killer cell responsiveness and homeostasis at steady-state by CD11c+ dendritic cells TT Luu, S Ganesan, AK Wagner, D Sarhan, S Meinke, N Garbi, ... Scientific reports 6 (1), 37996, 2016 | 25 | 2016 |
| Identification and characterisation of tertiary lymphoid organs in human type 1 diabetes É Korpos, N Kadri, S Loismann, CR Findeisen, F Arfuso, GW Burke, ... Diabetologia 64, 1626-1641, 2021 | 24 | 2021 |
| Downmodulation of effector functions in NK cells upon Toxoplasma gondii infection MA Sultana, A Du, B Carow, CM Angbjär, JM Weidner, S Kanatani, ... Infection and immunity 85 (10), 10.1128/iai. 00069-17, 2017 | 23 | 2017 |
| TLR‐Stimulated Eosinophils Mediate Recruitment and Activation of NK Cells In Vivo SM O'Flaherty, K Sutummaporn, WL Häggtoft, AP Worrall, M Rizzo, ... Scandinavian journal of immunology 85 (6), 417-424, 2017 | 22 | 2017 |
| Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results N Hossein-Khannazer, S Torabi, R Hosseinzadeh, S Shahrokh, ... Human Cell 34 (5), 1289-1300, 2021 | 21 | 2021 |
